AstraZeneca’s STRIDE shows improved outcomes for liver cancer patients
AstraZeneca has announced impressive results for its STRIDE regimen, delivering significantly improved outcomes for advanced liver cancer patients. The treatment…
All articles by Aidan McNamee
Aidan McNamee
Aidan joined Pharmaceutical Technology as a trainee reporter in 2023. With a background in data journalism, he has worked in consumer media covering a wide range of topics, and has a particular interest in big data, AI and the metaverse. Previously, Aidan worked with the Reach Data Unit as part of the Google News Initiative fellowship, and graduated with an MSc in Computational and Data Journalism from Cardiff University in 2022.
-
-
Pfizer’s Ngenla finally secures FDA approval following a rocky road to market
Pfizer has announced that the US Food and Drug Administration (FDA) has approved Ngenla (somatrogon-ghla), a paediatric growth hormone deficiency…
-
Pfizer takes on haemophilia B gene therapy market with new FDA application
Pfizer has announced that the US Food and Drug Administration (FDA) has accepted a biologics license application (BLA) for fidanacogene…
-
FDA approves Biostar’s Phase II/III plans with utidelone injectable for NSCLC
Synthetic biology biopharma Biostar Pharma announced is ready to advance its utidelone injectable (UTD1) in patients with locally advanced or…